Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Times Interest Earned (2022 - 2025)

Coeptis Therapeutics Holdings has reported Times Interest Earned over the past 4 years, most recently at $18.91 for Q4 2025.

  • Quarterly results put Times Interest Earned at $18.91 for Q4 2025, up 124.82% from a year ago — trailing twelve months through Dec 2025 was -$134.82 (down 183.2% YoY), and the annual figure for FY2025 was -$134.82, down 1251.36%.
  • Times Interest Earned for Q4 2025 was $18.91 at Coeptis Therapeutics Holdings, up from -$39.56 in the prior quarter.
  • Over the last five years, Times Interest Earned for COEPW hit a ceiling of $995.31 in Q4 2023 and a floor of -$489.76 in Q1 2024.
  • Median Times Interest Earned over the past 4 years was -$71.44 (2024), compared with a mean of -$44.48.
  • Peak annual rise in Times Interest Earned hit 215.5% in 2023, while the deepest fall reached 304.33% in 2023.
  • Coeptis Therapeutics Holdings' Times Interest Earned stood at $315.47 in 2022, then soared by 215.5% to $995.31 in 2023, then tumbled by 107.65% to -$76.18 in 2024, then skyrocketed by 124.82% to $18.91 in 2025.
  • The last three reported values for Times Interest Earned were $18.91 (Q4 2025), -$39.56 (Q3 2025), and -$66.7 (Q2 2025) per Business Quant data.